U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07067866) titled 'Weaning Approaches for Vasopressin in Sepsis' on July 06.
Brief Summary: In this study, we aim to evaluate the incidence of hypotension during vasopressin weaning by comparing two methods - titrated reduction versus abrupt withdrawal - through the conduct of a randomized clinical trial.
Study Start Date: Oct. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Septic Shock
Intervention:
OTHER: Titrated weaning of vasopressin.
The titrated group will follow the vasopressin weaning protocol used in the DOVSS study (reduction of 0.01 U/min per hour).
OTHER: Abrupt weaning of vasopressin.
The abrupt group will discontinue the vasopr...